Edition:
United Kingdom

People: Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

4.39USD
23 Jul 2019
Change (% chg)

$-0.14 (-3.09%)
Prev Close
$4.53
Open
$4.50
Day's High
$4.53
Day's Low
$4.26
Volume
35,465
Avg. Vol
45,885
52-wk High
$7.59
52-wk Low
$2.99

Harrell, Jamie 

Mr. Jamie Harrell is Executive Vice President of Marketing and Investor Relations of the Company. Mr. James Harrell, with over 25 years of biopharmaceutical experience, brings a breadth of commercial and marketing success to the organization. Mr. Harrell has held the positions of Vice President and General Manager of Specialty Pharmaceuticals for Covidien, running a 350-person commercial operations group. Additionally, he has held various commercial and leadership positions throughout his career in executive management, marketing and sales with organizations such as Covidien, Medimmune, Centocor, Inc. and Rhone Poulenc Rorer. Throughout his career, he helped to commercialize and market over 25 products, including the three blockbuster drugs, Lovenox®, Remicade® and Synagis®, each achieving over $1 Billion in annual US sales. He holds a B.S. degree in Business Administration, with a double major in Marketing and Economics, from Samford University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --